Terms: = Gastric cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
116 results:
1. Valproate modulates the activity of multidrug resistance efflux pumps, as a chemoresistance factor in gastric cancer cells.
Hosseini SA; Mirzaei SA; Kermani S; Yaghoobi H
Mol Biol Rep; 2024 Mar; 51(1):427. PubMed ID: 38498238
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells.
Hosseini SA; Ghatrehsamani M; Yaghoobi H; Elahian F; Mirzaei SA
Epigenomics; 2024 Mar; 16(5):277-292. PubMed ID: 38356395
[TBL] [Abstract] [Full Text] [Related]
3. Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line treatment of Advanced gastric cancer: K-Umbrella gastric cancer Study.
Lee CK; Kim HS; Jung M; Kim H; Bae WK; Koo DH; Jeung HC; Park SR; Hwang IG; Zang DY; Lee HW; Park S; Nam CM; Chung HC; Rha SY
J Clin Oncol; 2024 Jan; 42(3):348-357. PubMed ID: 37883723
[TBL] [Abstract] [Full Text] [Related]
4. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
5. Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer.
Chen M; Wang G; Xu Z; Sun J; Liu B; Chang L; Gu J; Ruan Y; Gao X; Song S
Cell Oncol (Dordr); 2024 Feb; 47(1):113-128. PubMed ID: 37578594
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer.
Zhang R; Chen X; Miao C; Chen Y; Li Y; Shen J; Yuan M; Chen M; Cheng J; Liu S; Sun Q; Wu J
J Ethnopharmacol; 2024 Jan; 318(Pt B):117013. PubMed ID: 37572927
[TBL] [Abstract] [Full Text] [Related]
7. DSC2 suppresses the growth of gastric cancer through the inhibition of nuclear translocation of γ-catenin and pten/PI3K/AKT signaling pathway.
Sun C; Wen K; Zhang B; Dong Y; Chen C; Neo SY; Leng B; Gao TT; Wu J
Aging (Albany NY); 2023 Jul; 15(13):6380-6399. PubMed ID: 37421607
[TBL] [Abstract] [Full Text] [Related]
8. Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial.
Hu Q; Oki E; Yamada T; Kashiwada T; Sonoda H; Kataoka M; Kawanaka H; Tsuji Y; Makiyama A; Nakashima Y; Ota M; Kimura Y; Yoshizumi T
Cancer Med; 2023 Aug; 12(15):16649-16660. PubMed ID: 37325934
[TBL] [Abstract] [Full Text] [Related]
9. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract] [Full Text] [Related]
10. [gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
11. Molecular mechanism of XB130 adaptor protein mediates trastuzumab resistance in gastric cancer.
Yang S; Wang B; Liao J; Hong Z; Zhong X; Chen S; Wu Z; Zhang X; Zuo Q
Clin Transl Oncol; 2023 Mar; 25(3):685-695. PubMed ID: 36284062
[TBL] [Abstract] [Full Text] [Related]
12. Small Cell and Other Rare Histologic Types of Cervical cancer.
Marchocki Z; Swift B; Covens A
Curr Oncol Rep; 2022 Nov; 24(11):1531-1539. PubMed ID: 35947285
[TBL] [Abstract] [Full Text] [Related]
13. MiR-17-5p Inhibits the Proliferation and Metastasis of gastric cancer Cells by Targeting pten Protein.
Yifei S; Chunxiao H; Dinuo L
Altern Ther Health Med; 2022 Nov; 28(8):23-29. PubMed ID: 35839114
[TBL] [Abstract] [Full Text] [Related]
14. Clinical significance of chromosomal integrity in gastric cancers.
Zhang R; Liu Z; Chang X; Gao Y; Han H; Liu X; Cai H; Fu Q; Liu L; Yin K
Int J Biol Markers; 2022 Sep; 37(3):296-305. PubMed ID: 35722719
[TBL] [Abstract] [Full Text] [Related]
15. Design, semi-synthesis and bioactivity evaluation of novel podophyllotoxin derivatives as potent anti-tumor agents.
Sun W; Sun F; Meng J; Cao X; Zhao S; Wang C; Li L; Jiang P
Bioorg Chem; 2022 Sep; 126():105906. PubMed ID: 35661529
[TBL] [Abstract] [Full Text] [Related]
16. Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy.
Huh YJ; Cho SY; Cho MS; Lee KE; Lee JH
Genes Genomics; 2022 Nov; 44(11):1425-1435. PubMed ID: 35622232
[TBL] [Abstract] [Full Text] [Related]
17. TULP3 silencing suppresses cell proliferation, migration and invasion in gastric cancer via the pten/Akt/Snail pathway.
Song J; Fu Q; Liu G; Zhang C; Wang Y; Tao S; Liu R; Li Z
Cancer Treat Res Commun; 2022; 31():100551. PubMed ID: 35344762
[TBL] [Abstract] [Full Text] [Related]
18. Metformin and MiR-365 synergistically promote the apoptosis of gastric cancer cells via MiR-365-pten-AMPK axis.
Huang F; Xiang Y; Li T; Huang Y; Wang J; Zhang HM; Li HH; Dai ZT; Li JP; Li H; Zhou J; Liao XH
Pathol Res Pract; 2022 Feb; 230():153740. PubMed ID: 35007850
[TBL] [Abstract] [Full Text] [Related]
19. A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer.
Ning G; Zhu Q; Kang W; Lee H; Maher L; Suh YS; Michaud M; Silva M; Kwon JY; Zhang C; Lee C
BMC Cancer; 2021 Aug; 21(1):923. PubMed ID: 34399705
[TBL] [Abstract] [Full Text] [Related]
20. Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a pten conditional deletion mouse model.
Zhu CH; Peng SQ; Cui LL; Cao W; Zhang LS; Zhao ZM; Jia L; Zhang TF; Guo JB; Pang C
Gastric Cancer; 2022 Jan; 25(1):96-106. PubMed ID: 34370147
[TBL] [Abstract] [Full Text] [Related]
[Next]
